한빛사논문 | BRIC

정기훈 님의 논문 목록

서울대학교 의과대학

CV File 243 kb

Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
- Exp. Mol. Med., 01 November 2023 | https://doi.org/10.1038/s12276-023-01114-w
- 2023-11
- 생명과학
- 한빛사논문
Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes
- Nat. Cancer, Published: 22 December 2022 | doi: 10.1038/s43018-022-00479-7
- 2022-12
- 바이오·의료융합
- 한빛사논문
PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer
- Nat. Commun., Published 22 October 2022 | https://doi.org/10.1038/s41467-022-33991-6
- 2022-10
- 생명과학
- 한빛사논문
MarcoPolo: a method to discover differentially expressed genes in single-cell RNA-seq data without depending on prior clustering
- Nucleic Acids Res., Published: 14 April 2022 | https://doi.org/10.1093/nar/gkac216
- 2022-04
- 의약학
- 한빛사논문
Nano-assembly of a Chemically Tailored Cas9 Ribonucleoprotein for In Vivo Gene Editing and Cancer Immunotherapy
- Chem. Mater., Publication Date:December 20, 2021 | https://doi.org/10.1021/acs.chemmater.1c02844
- 2021-12
- 바이오·의료융합
- 한빛사논문
- 정기훈(Harvard Medical School)
Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer
- Proc. Natl. Acad. Sci. USA, Published online before print September 12, 2017 | doi: 10.1073/pnas.1710754114
- 2017-09
- 생명과학
- 한빛사논문
- 정기훈(Harvard Medical School and Massachusetts General Hospital)
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
- J. Clin. Invest., Published July 10, 2017 | doi:10.1172/JCI93182
- 2017-07
- 생명과학
- 한빛사논문
Endoscopic Time-Lapse Imaging of Immune Cells in Infarcted Mouse Hearts
- Circ. Res., 2013; 112: 891-899. Published online before print February 7, 2013, doi: 10.1161/CIRCRESAHA.111.300484
- 2013-02
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기